AJP - Renal AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (May 12, 2004). doi:10.1152/ajprenal.00070.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/F512    most recent
00070.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAPCHAK, P. H.
Right arrow Articles by BRISCOE, D. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAPCHAK, P. H.
Right arrow Articles by BRISCOE, D. M
Submitted on March 4, 2004
Accepted on May 7, 2004

CD40-INDUCED TRANSCRIPTIONAL ACTIVATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INVOLVES A 68BP REGION OF THE PROMOTER CONTAINING A CpG ISLAND

PETER H. LAPCHAK1, MICHAEL MELTER1, SOUMITRO PAL1, JESSE A. FLAXENBURG1, CHRISTOPHER GEEHAN2, MARKUS H. FRANK1, DEBABRATA MUKHOPADHYAY3, and DAVID M BRISCOE1*

1 DEPARTMENT OF MEDICINE, CHILDREN'S HOSPITAL BOSTON, BOSTON, MA, USA; DEPARTMENT OF PATHOLOGY, BETH ISRAEL DEACONESS MEDICAL CENTER AND HARVARD MEDICAL SCHOOL, BOSTON, MA, USA
2 DEPARTMENT OF MEDICINE, CHILDREN'S HOSPITAL BOSTON, BOSTON, MA, USA
3 DEPARTMENT OF PEDIATRICS HAVARD MEDICAL SCHOOL, CHILDREN'S HOSPTIAL, BOSTON, MA, USA; DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, MAYO CLINIC, ROCHESTER, MINN, USA; THE MAYO CLINIC CANCER CENTER, MAYO CLINIC, ROCHESTER, MINN, USA

* To whom correspondence should be addressed. E-mail: DAVID.BRISCOE{at}TCH.HARVARD.EDU.

Vascular endothelial growth factor (VEGF) is produced by several cell types in the kidney and its expression is tightly regulated for the maintenance of normal renal physiology. Increases or decreases in its expression are associated with proteinuria and renal disease. Recently, we found that the expression of VEGF is markedly induced following interactions between CD40 ligand (CD40L) and CD40. Here, endothelial cells (EC) or Jurkat T cell lines were transiently transfected with luciferase reporter constructs under the control of the human VEGF promoter and were treated with human soluble CD40L (sCD40L). We identified a CD40- responsive 68 bp region (bp -50 to +18) of the promoter; and 43 bp's within this region (bp -25 to +18) that have 97% homology to a sequence of CpG dinucleotides. A computerized search revealed that the CpG region has putative binding domains for the transcriptional repressor protein methyl CpG binding protein-2 (MeCP2). In EMSA, we found that the 43bp methylated sequence formed four complex(es) with nuclear extracts from untreated EC; and reduced binding of at least one complex when nuclear lysates from sCD40L-activated EC (30 min) were used. Supershift analysis using anti-MeCP2 demonstrated that most of the complex(es) in both untreated and sCD40L-activated EC involved interactions between the 43bp DNA and MeCP2. In addition, we found that other CpG binding proteins may also interact with this region of the promoter. Taken together, this is the first demonstration that CpG binding transcriptional repressor proteins including MeCP2 may be of importance in VEGF biology.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
L. Xu and R. K. Jain
Down-Regulation of Placenta Growth Factor by Promoter Hypermethylation in Human Lung and Colon Carcinoma
Mol. Cancer Res., September 1, 2007; 5(9): 873 - 880.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.